The Recall Registry
Recall data checked 13 hours ago

Home › Prescription medicine › Amneal Pharmaceuticals of New York, LLC —…

Food & drug recall · FDAMarch 25, 2024Serious

Amneal Pharmaceuticals of New York, LLC — Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only

Do not stop taking this without speaking to your pharmacist or doctor.

What’s wrong

Failed Dissolution Specifications

The Recall Registry rates this serious — FDA Class II: temporary or medically reversible health harm.

What to do

Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.

Who to contact: Recalling firm: Amneal Pharmaceuticals of New York, LLC

The product

Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2.

Details

Units affected
2784 bottles
Recall date
March 25, 2024
Brand
Amneal Pharmaceuticals of New York, LLC
Model, lot or SKU numbers
Lot #: BJ01922A, exp. date 03/2024
Where it was distributed

US Nationwide

The official notice

This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.

Their exact wording: “Amneal Pharmaceuticals of New York, LLC — Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2.”

Read it on FDA →

Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.

Filed under: Prescription medicine

Other prescription medicine recalls